Semilunar valves are the two crescent-shaped gateways that guard the exits of your heart, preventing blood from sliding back into the pumping chambers after each beat. One sits at the outlet of the left ventricle (the aortic valve) and the other at the outlet of the right ventricle (the pulmonary valve). Though they share a basic design and a common origin during fetal development, they face very different working conditions and are prone to different problems. The aortic valve, exposed to the full force of systemic blood pressure, bears the brunt of age-related disease, while the pulmonary valve deals with gentler pressures but can be affected by congenital defects and post-surgical complications.
Where They Sit and What They Look Like
Each semilunar valve normally has three pocket-like flaps, called cusps or leaflets, arranged in a circle. When the ventricle contracts, blood pushes the cusps open and flows into the artery beyond. When the ventricle relaxes, the cusps snap shut like small parachutes filling with backflow, sealing the opening and keeping blood moving in one direction. The name “semilunar” comes from the half-moon shape each cusp takes when viewed from above.
The aortic valve sits between the left ventricle and the aorta, the body’s main highway for oxygenated blood. Just above it are small bulges in the aortic wall called the sinuses of Valsalva, and two of these sinuses contain the openings of the coronary arteries, which feed the heart muscle itself. The pulmonary valve sits between the right ventricle and the pulmonary artery, directing oxygen-depleted blood toward the lungs. It has no coronary artery openings nearby, and it works under much lower pressure.
Three Layers, One Design
Despite looking thin and delicate, each semilunar valve leaflet is an engineered composite. Histological studies show three distinct layers stacked together: the fibrosa, the spongiosa, and the ventricularis.1PubMed Central. Histological assessment of the human heart valves and its relationship with age The fibrosa, on the arterial side, is packed with collagen fibers that resist stretching. The ventricularis, on the side facing the ventricle, is rich in elastin, the protein that lets tissue spring back to shape. Sandwiched between them is the spongiosa, a cushioning layer of proteoglycans that absorbs shock during the billions of open-close cycles a valve will perform over a lifetime.2PubMed Central. Heart valve structure and function in development and disease
Although the aortic and pulmonary valves share this three-layer blueprint, they are not identical twins. The aortic valve has a higher density of cells in its fibrosa and ventricularis layers than the pulmonary valve does.3PubMed. Cell composition of the human pulmonary valve: a comparative study with the aortic valve–the VESALIO Project Biomechanical testing also reveals differences: pulmonary valve cusps can handle higher stress in the circumferential direction than aortic cusps, even though the aortic valve faces higher pressures in the body.4PubMed. Comparison of biomechanical and structural properties between human aortic and pulmonary valve These subtle structural distinctions matter when surgeons consider swapping one valve for the other, as in the Ross procedure discussed later.
How the Valves Form Before Birth
Both semilunar valves trace back to a single embryonic structure called the conotruncus, a shared outflow channel that later divides to form the aorta and pulmonary artery. During early heart development, cells lining the inside of this outflow tract undergo a transformation: they shift from a flat epithelial state into mobile, tissue-building cells. These transformed cells go on to form the bulk of the semilunar valve leaflets.5PubMed Central. The Neural Crest in Cardiac Congenital Anomalies Because the two valves begin as one structure, disruptions during this embryonic partitioning can produce congenital defects in either or both valves.
The Vortex That Helps the Valve Close
Semilunar valves do not slam shut passively when blood tries to flow backward. Their closure is more graceful than that, and the sinuses behind the leaflets play a key role. As blood jets forward through the open valve, small spinning currents, or vortices, form inside each sinus. These vortices push the leaflet edges toward the center of the opening while the main stream of blood is still flowing forward.6PubMed. Effect of the sinus of Valsalva on fluid structure interaction of aortic valve By the time the ventricle finishes contracting, the leaflets are already partly closed, which means very little blood leaks backward before the seal is complete.7PubMed. Effect of the sinus of valsalva on the closing motion of bileaflet prosthetic heart valves
The dynamics are not identical on both sides of the heart. The aortic root expands roughly twice as much as the pulmonary root during each heartbeat, and the three sinuses of the aortic root expand unevenly, with the right sinus expanding most.8European Journal of Cardio-Thoracic Surgery. Aortic and pulmonary root: are their dynamics similar? This asymmetry matters because it affects how quickly and evenly the vortices develop, which in turn influences how smoothly the valve closes. Computational modeling has shown that when leaflets stiffen, as happens with aging or calcification, the sinus vortex hangs around longer and delays the pressure changes needed for crisp closure.9PubMed Central. Vortex Dynamics in the Sinus of Valsalva
Why the Aortic Valve’s Neighbors Matter
A feature unique to the aortic valve is the presence of the coronary artery openings, or ostia, sitting right inside two of its three sinuses. The heart muscle gets most of its blood supply during the relaxation phase of the heartbeat, when the aortic valve is closed and blood fills the sinuses. The pressure difference between the aortic root and the heart muscle tissue drives flow into the coronary arteries.10PubMed. A numerical study of the hemodynamic effect of the aortic valve on coronary flow Computational studies confirm that a substantial portion of blood near the sinus wall gets diverted into the coronary ostia rather than recirculating back toward the main blood jet.11PubMed Central. The impact of coronary outflow and non-Newtonian fluid property on aortic valve haemodynamics This intimate relationship means that diseases affecting the aortic valve or root can also compromise blood flow to the heart muscle itself, compounding the damage.
The Bicuspid Aortic Valve
The most common congenital heart defect affecting the semilunar valves is the bicuspid aortic valve, in which the valve forms with two cusps instead of three. It affects roughly one to two percent of the population. Despite functioning adequately for years or even decades, bicuspid valves are predisposed to early calcification and make up about half of all cases of aortic valve narrowing (stenosis).12PubMed Central. The congenital bicuspid aortic valve can experience high-frequency unsteady shear stresses on its leaflet surface
Part of the explanation is mechanical. Modeling studies show that the abnormal two-cusp geometry produces a lopsided jet of blood that collides with the aortic wall, and the fluid forces on the leaflet surfaces are much more turbulent and variable than in a normal three-cusp valve.12PubMed Central. The congenital bicuspid aortic valve can experience high-frequency unsteady shear stresses on its leaflet surface These erratic shear stresses can trigger inflammatory and calcification pathways in the tissue, accelerating damage well before old age. Genetics also plays a role, since bicuspid valves run in families and are associated with abnormalities in the aortic wall itself, but the mechanical stress alone is enough to shorten the valve’s working life.
Pulmonary Valve Stenosis
On the right side of the heart, the most common congenital problem is pulmonary valve stenosis, a narrowing that forces the right ventricle to work harder to push blood to the lungs. It accounts for roughly seven to twelve percent of all congenital heart diseases and can appear in isolation or alongside other defects.13PubMed Central. Pulmonary Valve Stenosis: From Diagnosis to Current Management Techniques and Future Prospects Mild cases may never need treatment, but moderate to severe narrowing usually calls for intervention. Balloon valvuloplasty, in which a catheter-mounted balloon is inflated across the narrowed valve, has been the standard treatment for decades and works well for most patients.
After successful treatment, the pulmonary valve sometimes becomes leaky rather than tight, a trade that is generally tolerated well on the low-pressure right side. However, leakiness (regurgitation) can gradually stretch the right ventricle, especially in patients who have also undergone surgical repair for tetralogy of Fallot, a complex congenital heart defect. Monitoring the rate at which the right ventricle dilates helps clinicians decide when pulmonary valve replacement is needed.14PubMed Central. Right ventricular dilatation in patients with pulmonary regurgitation after repair of tetralogy of Fallot: How fast does it progress?
Calcific Aortic Valve Disease
Age-related calcification is the dominant acquired disease of the semilunar valves and overwhelmingly affects the aortic valve. For a long time, surgeons assumed calcific aortic valve disease was just passive wear and tear, calcium slowly depositing on tired tissue the way limescale builds up in old pipes. That view has been overturned. Research now recognizes it as an actively regulated disease process involving inflammation, lipid infiltration, and bone-like mineralization driven by living cells within the leaflet.15PubMed Central. Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease
Because many of the early risk factors overlap with atherosclerosis (the disease behind most heart attacks), researchers hoped that cholesterol-lowering statins might slow aortic valve calcification. The logic seemed sound: lower the lipid burden, slow the damage. But clinical trials consistently showed otherwise. In the large SEAS trial, nearly 1,900 patients with mild-to-moderate aortic stenosis were given either a statin-ezetimibe combination or a placebo for over four years. Despite a large drop in LDL cholesterol, there was no effect on valve disease progression.16European Heart Journal. Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy Other well-designed trials reached the same conclusion.17Heart. Aortic valve calcification: basic science to clinical practice The current understanding is that while lipid accumulation may help initiate the disease, once the mineralization machinery is active, lowering cholesterol does not shut it down. No drug has yet been proven to halt or reverse established calcific aortic valve disease, which means valve replacement remains the only definitive treatment for severe cases.
Aortic Regurgitation
When the aortic valve leaks rather than narrows, the condition is called aortic regurgitation. Blood that was ejected into the aorta slips back into the left ventricle, forcing it to handle an extra volume with every beat. Over time, the ventricle stretches and eventually weakens. Clinicians classify aortic regurgitation by what has gone wrong mechanically:
- Type I: The leaflets themselves move normally, but the surrounding aortic root or ring has dilated, pulling the cusps apart so they no longer seal.
- Type II: One or more leaflets prolapse, flopping past the closure line due to torn or elongated supporting tissue.
- Type III: The leaflets are stiff and restricted from fibrosis or calcification, preventing them from meeting fully.
This classification, often called the El-Khoury system, guides whether a leaky valve can be repaired or needs to be replaced entirely.18PubMed Central. Unveiling the Transverse Fold: An Underrecognized Cause of Severe Aortic Regurgitation Type II, for example, is often repairable because the leaflet tissue is still flexible and just needs to be repositioned. Type III is harder to fix because the tissue itself is damaged.
Infective Endocarditis on Semilunar Valves
Infective endocarditis, an infection of the heart valve surface, can strike any valve but has a particular affinity for valves that are already abnormal. Bacteria circulating in the blood latch onto damaged or roughened valve surfaces, forming clumps called vegetations. These masses are a tangle of platelets, fibrin, bacteria, and immune cells, and they can grow large enough to obstruct the valve, tear through the leaflet tissue, or break off and travel to distant organs as infected emboli.19PubMed. Pathology and pathogenesis of infective endocarditis in native heart valves
Right-sided endocarditis, affecting the pulmonary valve, is far less common than left-sided disease but is seen disproportionately in people who inject drugs, because bacteria from contaminated needles enter the venous system and reach the right heart first. In severe cases, the infection can completely destroy the pulmonary valve, sometimes requiring surgical replacement.20PubMed Central. Surgical Treatment of Infective Endocarditis in Pulmonary Position—15 Years Single Centre Experience The accepted model for how endocarditis develops starts with endothelial injury on the valve surface, followed by deposition of a small sterile clot, and then colonization of that clot by bacteria during a brief episode of bacteria in the bloodstream.
How Doctors Evaluate These Valves
Echocardiography, an ultrasound of the heart, is the first-line tool for assessing semilunar valve problems. It can show the valve’s structure, measure how fast blood is moving through it, and calculate pressure differences across a narrowed valve. For stenosis, clinicians estimate how severe the narrowing is by measuring the pressure gradient: the bigger the pressure drop across the valve, the tighter the obstruction.21PubMed. Assessment of aortic and pulmonic stenosis by echocardiography
There is a practical catch with pulmonary valve stenosis, though. The most commonly reported number, the peak instantaneous gradient, tends to overstate the severity compared to what is measured directly in the catheterization lab. One study of 90 patients found that the peak Doppler gradient systematically overestimated the catheter-measured gradient by roughly 21 to 26 mmHg, while the mean Doppler gradient was much closer to reality. The takeaway for clinicians is that relying on the peak gradient alone may lead to unnecessary interventions.22Journal of the American Society of Echocardiography. Echocardiographic Assessment of Isolated Pulmonary Valve Stenosis: Which Outpatient Doppler Gradient Has the Most Clinical Validity?
Beyond standard ultrasound, emerging tools are expanding what clinicians and researchers can visualize. Computer-aided design combined with 3D printing and four-dimensional flow MRI now allows teams to build physical models of semilunar valves and study the flow patterns through them in detail.23PubMed Central. Simulation of semilunar valve function: computer-aided design, 3D printing and flow assessment with MR These models are useful for pre-surgical planning and for testing new prosthetic valve designs before they go into a patient.
Replacing a Semilunar Valve
When a semilunar valve is too damaged to repair, replacement is the standard treatment. Two broad categories of prosthetic valves exist: mechanical valves, made from engineered materials, and bioprosthetic valves, typically constructed from treated animal tissue. Mechanical valves last a long time but require lifelong blood-thinning medication. Bioprosthetic valves do not usually require blood thinners, but they are prone to structural degeneration over time, with calcification being the most common form of failure.24PubMed Central. Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification
The mechanisms behind bioprosthetic valve calcification have turned out to be more complex than early researchers expected. The chemical treatment used to prepare animal tissue (glutaraldehyde fixation) creates residual antigens that can provoke an immune response. Recent evidence suggests that the body’s reaction to bioprosthetic tissue resembles a slow-motion version of transplant rejection combined with atherosclerosis-like changes, rather than simple wear and tear.25PubMed Central. Degeneration of Bioprosthetic Heart Valves: Update 2020 Newer processing techniques and emerging polymer-based materials aim to solve this durability problem by reducing immunogenicity and eliminating residual antigens.26PubMed Central. Advancements and Perspectives in the Bioprosthetic Heart Valve: A Comprehensive Review on Biomaterial Processing and Emerging Polymeric Materials
For the aortic valve specifically, a major shift over the past two decades has been the rise of transcatheter aortic valve replacement (TAVR), in which a new valve is delivered through a catheter, usually threaded up from the leg artery, and expanded inside the diseased native valve. Data from the PARTNER trial showed that TAVR valves had small, stable pressure gradients over five years of follow-up, comparable to those of surgically implanted valves.27JAMA Cardiology. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial Simulation studies have also confirmed that the two approaches produce similar overall hemodynamic performance, though TAVR tends to produce slightly higher gradients and wall shear stresses.28PubMed. Comparison of hemodynamics in biological surgical aortic valve replacement and transcatheter aortic valve implantation: An in-silico study
The Ross Procedure and Autograft Remodeling
One of the more inventive solutions for a diseased aortic valve is the Ross procedure: the patient’s own pulmonary valve is moved into the aortic position, and a donor valve is placed in the now-empty pulmonary spot. The reasoning is elegant. The pulmonary valve is living tissue, so it can potentially grow, repair itself, and last longer than any prosthetic. And because both semilunar valves develop from the same embryonic structure, researchers have hypothesized that a transplanted pulmonary valve has an innate ability to adapt toward an aortic-like tissue profile once exposed to systemic pressures.29PubMed Central. Understanding Pulmonary Autograft Remodeling After the Ross Procedure: Stick to the Facts
That adaptation is real but imperfect. Studies of autografts that were later explanted show that the pulmonary wall thickens significantly after being moved to the aortic position, likely a compensatory response to the higher pressures it now faces.30PubMed Central. Range of Pulmonary Autograft Responses to Systemic Pressure Immediately After Ross Procedure However, thickened is not the same as normal. Explanted autografts tend to be less stiff than a normal aortic root, which means they can dilate over time, eventually causing regurgitation and the need for reoperation. The current thinking is that protecting the autograft during the early adaptation phase, often with some form of external support to prevent stretching, is crucial to avoiding a cascade of harmful remodeling.29PubMed Central. Understanding Pulmonary Autograft Remodeling After the Ross Procedure: Stick to the Facts Surgeons are still working out the ideal balance: support tight enough to prevent dilation, yet loose enough to let the living tissue remodel naturally rather than atrophy from disuse.
Why the Pulmonary Valve Gets Less Attention
If you read about heart valve disease, you will notice that the aortic valve dominates the conversation. This is not a coincidence. The aortic valve operates under systemic pressure, roughly four to five times higher than what the pulmonary valve experiences, and that relentless mechanical load makes it far more vulnerable to age-related calcification and wear. Pulmonary valve disease in adults is almost entirely a consequence of congenital defects or prior surgery rather than the degenerative process that drives most aortic valve disease.
This pressure difference also explains why a leaky pulmonary valve is tolerated much better than a leaky aortic valve. The right ventricle can handle the extra volume from regurgitation for years before it starts to struggle, partly because the pulmonary circulation is a low-resistance, low-pressure system. In contrast, even moderate aortic regurgitation forces the muscular left ventricle to cope with both the high-pressure forward load and a significant backward leak, a combination that leads to stretching and failure more quickly. For clinicians, this disparity means that the thresholds for intervening on the two valves are quite different. An aortic valve problem may warrant surgery much sooner than an equivalent degree of pulmonary valve dysfunction.